George Vlachogiannis Shares a Study on Functional Outcomes after Sarcoma Surgery
George Vlachogiannis, Managing Editor of Cancer Control at Sage, shared a post on LinkedIn:
“Functional and Oncological Outcomes in Patients With Surgically Treated Lower Extremity Soft Tissue Sarcoma
Dr Ahmet Salduz and colleagues from Istanbul Faculty of Medicine report a retrospective cohort of 52 patients with lower-extremity soft tissue sarcoma treated with limb-sparing surgery plus radiotherapy.
The five-year overall survival was 72% and local control 69%. Pelvic location and metastases worsened outcomes, and metastasis independently predicted survival. Adjuvant (post-op) conventional radiotherapy delivered significantly better function (MSTS/TESS) and quality of life (QLQ-C30) than hypofractionated neoadjuvant radiotherapy, without sacrificing oncologic control.
Postoperative, conventionally fractionated radiotherapy may better support functional recovery and quality of life in patients with lower-extremity soft tissue sarcoma treated with limb-sparing surgery plus radiotherapy.”
Title: Functional and Oncological Outcomes in Patients With Surgically Treated Lower Extremity Soft Tissue Sarcoma
Authors: Zeyneb İrem Yuksel Salduz, Yaşar Samet Gökçeoğlu, Ayşe Nur İncesu, Serkan Bayram, Ahmet Salduz
Read the Full Article.
More posts featuring George Vlachogiannis.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023